BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33228404)

  • 1. Association of adverse outcomes of intrahepatic cholestasis of pregnancy with zonulin levels.
    Deniz CD; Ozler S; Sayın FK
    J Obstet Gynaecol; 2021 Aug; 41(6):904-909. PubMed ID: 33228404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Do Serum Zonulin Levels Change in Gestational Diabetes Mellitus, Pregnancy Cholestasis, and the Coexistence of Both Diseases?
    Güvey H; Çelik S; Çalışkan CS; Yılmaz Z; Yılmaz M; Erten Ö; Tinelli A
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Ovadia C; Seed PT; Sklavounos A; Geenes V; Di Ilio C; Chambers J; Kohari K; Bacq Y; Bozkurt N; Brun-Furrer R; Bull L; Estiú MC; Grymowicz M; Gunaydin B; Hague WM; Haslinger C; Hu Y; Kawakita T; Kebapcilar AG; Kebapcilar L; Kondrackienė J; Koster MPH; Kowalska-Kańka A; Kupčinskas L; Lee RH; Locatelli A; Macias RIR; Marschall HU; Oudijk MA; Raz Y; Rimon E; Shan D; Shao Y; Tribe R; Tripodi V; Yayla Abide C; Yenidede I; Thornton JG; Chappell LC; Williamson C
    Lancet; 2019 Mar; 393(10174):899-909. PubMed ID: 30773280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A; Maciejewski T; Niemiec KT
    Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B; Özler S
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study.
    Geenes V; Chappell LC; Seed PT; Steer PJ; Knight M; Williamson C
    Hepatology; 2014 Apr; 59(4):1482-91. PubMed ID: 23857305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic cholestasis of pregnancy and its association with preeclampsia and gestational diabetes: a retrospective analysis.
    Avsar HA; Atlıhan U; Ata C; Erkılınc S
    Arch Gynecol Obstet; 2024 Jul; 310(1):221-227. PubMed ID: 38625544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels.
    Brouwers L; Koster MP; Page-Christiaens GC; Kemperman H; Boon J; Evers IM; Bogte A; Oudijk MA
    Am J Obstet Gynecol; 2015 Jan; 212(1):100.e1-7. PubMed ID: 25046809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of interleukin-18, 12 and tumor necrosis factor-α in intrahepatic cholestasis of pregnancy].
    Jin P; Shao Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):329-32. PubMed ID: 21733366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can routine laboratory parameters predict adverse pregnancy outcomes in intrahepatic cholestasis of pregnancy?
    Oztas E; Erkenekli K; Ozler S; Ersoy AO; Kurt M; Oztas E; Uygur D; Danisman N
    J Perinat Med; 2015 Nov; 43(6):667-74. PubMed ID: 25294714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of maternal bile Acid quantification in intrahepatic cholestasis of pregnancy as an adverse perinatal outcome predictor.
    Garcia-Flores J; Cañamares M; Cruceyra M; Garicano A; Espada M; Lopez A; Tamarit I
    Gynecol Obstet Invest; 2015; 79(4):222-8. PubMed ID: 25720981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis.
    Cui D; Zhong Y; Zhang L; Du H
    J Obstet Gynaecol Res; 2017 Sep; 43(9):1411-1420. PubMed ID: 28691322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is increased maternal endothelin-1 concentration associated with neonatal asphyxia and preterm delivery in intrahepatic cholestasis of pregnancy?
    Kebapcilar AG; Kebapcilar L; Taner CE; Bozkaya G; Sahin G; Gokulu SG
    Arch Gynecol Obstet; 2010 Dec; 282(6):617-21. PubMed ID: 19862540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of postprandial bile acids in prediction of perinatal outcome in intrahepatic cholestasis of pregnancy.
    Sargın Oruç A; Seçkin B; Özcan N; Özyer S; Uzunlar Ö; Danışman N
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1883-9. PubMed ID: 25056466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical practice guidelines of the Team of Experts of the Polish Gynecological Society: management of the intrahepatic cholestasis of pregnancy].
    Leszczyńska-Gorzelak B; Oleszczuk J; Marciniak B; Poreba R; Oszukowski P; Wielgoś M; Czajkowski K;
    Ginekol Pol; 2012 Sep; 83(9):713-7. PubMed ID: 23342903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early and later intrahepatic cholestasis of pregnancy (ICP): Study of adverse pregnancy outcomes].
    Labbe C; Delesalle C; Creveuil C; Dreyfus M
    Gynecol Obstet Fertil Senol; 2018 Apr; 46(4):388-394. PubMed ID: 29602694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of small heterodimer partner and FGF 19 levels in prediction of perinatal morbidity in intrahepatic cholestasis of pregnancy.
    Bayram M; Irak K; Cifci S; Koksal AR; Kazezoglu C; Acar Z; Ozarı HO; Alkim H
    J Obstet Gynaecol; 2022 Jul; 42(5):1174-1178. PubMed ID: 35156505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.
    Glantz A; Marschall HU; Mattsson LA
    Hepatology; 2004 Aug; 40(2):467-74. PubMed ID: 15368452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of fetal left ventricular modified myocardial performance index and its prognostic significance for adverse perinatal outcome in intrahepatic cholestasis of pregnancy.
    Ozel A; Alici Davutoglu E; Eric Ozdemir M; Oztunc F; Madazli R
    J Matern Fetal Neonatal Med; 2020 Jun; 33(12):2000-2005. PubMed ID: 30309274
    [No Abstract]   [Full Text] [Related]  

  • 20. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.